The information presented in these slides is provided as part of additional Risk Minimisation Program for Duodopa targeted to minimise:
–Gastrointestinal (GI) events
–Procedure-related risks associated with the levodopa – carbidopa intestinal gel (LCIG) system
This guide provides advice to healthcare professionals on how to minimise PEG-J tube related complications in patients receiving Duodopa therapy. It should be used in conjunction with any local guidance and the CADD-Legacy 1400 pump instruction manual.
Important Additional Risk Minimisation Information for Healthcare Professionals
Training for AbbVie Duodopa Specialists on LCIG System, PEG-J Placement,
Aftercare and Minimisation of Procedure Complications
You are trying to reach document intended for healthcare professionals only.
Are you a healthcare professional?
Log in or sign up to avoid further verifications.
AbbVie House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire, SL6 4UB, UK